Opioid Free Anesthesia in Maxillofacial Surgery

NCT ID: NCT05031676

Last Updated: 2021-09-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

66 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-02-15

Study Completion Date

2020-10-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Opioid free anesthesia is a promising practice in anesthesia. Studies already carried out have compared OFA to an opioid or "opioid anesthesia" (OA) protocol without the use of antihyperalgesic in the OA protocol. Most of the studies currently available have been carried out in Europe, America and a few in Asia under conditions other than those available in precarious situations.That's why we decide to conduct a study to evaluate the effectiveness of an OFA protocol in maxillofacial surgery in Burkina Faso.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The patients were recruited at the University Hospital of Souro Sanou in Bobo Dioulasso

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Maxillofacial Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The patients were randomized during the pre-anesthetic visit in two groups 1 and 2. They were randomized in blocks of four so that, in each block of four patients, there were two patients for the protocol 1 and two patients for the protocol 2.
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants
Participant does not know the protocol which receive but i

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group 1

Intervention consists at induction : direct intravenous lidocaine 1.5 mg/kg; clonidine 2 μg/kg in 250 ml of isotonic saline, started as soon as the venous route is taken and over a period of approximately 15 minutes; magnesium sulfate 50 mg/kg in the same isotonic saline as clonidine.

Group Type EXPERIMENTAL

opioid free anesthesia

Intervention Type OTHER

Maintenance of anesthesia was done with halothane. The incision was allowed at 1.2 MAC of halothane. This halogen was administered according to the hemodynamic parameters and the habits of the anesthesia team. Before waking up, all the patients benefited from preventive analgesia with 1 g paracetamol combined with 20 mg nefopam by slow intravenous injection over approximately 15 minutes.

group 2

In classic induction: fentanyl at a dose of 2 µg/kg. Following induction in all patients consisted of the administration of propofol 2-3 mg/kg in titration, rocuronium 0.6 mg/kg, ketamine 0.5 mg/kg, methylprednisolone 120 mg.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

opioid free anesthesia

Maintenance of anesthesia was done with halothane. The incision was allowed at 1.2 MAC of halothane. This halogen was administered according to the hemodynamic parameters and the habits of the anesthesia team. Before waking up, all the patients benefited from preventive analgesia with 1 g paracetamol combined with 20 mg nefopam by slow intravenous injection over approximately 15 minutes.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients aged between 15 and 65 years, admitted to the central operating room of the hospital for maxillofacial surgery.

Exclusion Criteria

* Known or suspected coronary artery disease on preoperative consultation;
* Unstable arterial hypertension
* Insulin-dependent diabetes
* Second degree atrioventricular block
* Neuro-vegetative dysautonomia;
* known allergy or intolerance to a drug of the protocols
Minimum Eligible Age

15 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Université NAZI BONI

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ismael Guibla

Anaesthesist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ismael Guibla, Doctor

Role: PRINCIPAL_INVESTIGATOR

University Hospital Souro Sanou, Burkina Faso

Charles Ilboudo, Doctor

Role: STUDY_CHAIR

University Hospital Souro Sanou, Burkina Faso

Bertille Ki, Professor

Role: STUDY_CHAIR

Univesity of Joseph KI-ZERBO, Health sciences institute

Jean Paul Lechat, Doctor

Role: STUDY_CHAIR

Hospital of Charleroi (GHdC), Belgium

Cheick Bougouma, Doctor

Role: STUDY_CHAIR

Univesity of Joseph KI-ZERBO, Health sciences institute

Alain Traore, Professor

Role: STUDY_DIRECTOR

University of Nazi Boni, Health sciences institute

Flavien Kabore, Professor

Role: STUDY_DIRECTOR

Univesity of Joseph KI-ZERBO, Health sciences institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Guibla

Bobo-Dioulasso, Houet, Burkina Faso

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Burkina Faso

References

Explore related publications, articles, or registry entries linked to this study.

De Kock M. L'anesthésie sans opiacés : anecdote ou nécessité ? Douleur et Analgésie. 2014 sept;27(3):145-148.

Reference Type RESULT

Beloeil H. Anesthésie sans opiacés. Anesth Réanimation. 2018 may;4(3):215-218.

Reference Type RESULT

Mulier J. Opioid free general anesthesia: A paradigm shift? Rev Esp Anestesiol Reanim. 2017 Oct;64(8):427-430. doi: 10.1016/j.redar.2017.03.004. Epub 2017 Apr 18. No abstract available. English, Spanish.

Reference Type RESULT
PMID: 28431750 (View on PubMed)

Parsa FD, Cheng J, Stephan B, Castel N, Kim L, Murariu D, Parsa AA. Bilateral Breast Reduction Without Opioid Analgesics: A Comparative Study. Aesthet Surg J. 2017 Sep 1;37(8):892-899. doi: 10.1093/asj/sjx038.

Reference Type RESULT
PMID: 28333299 (View on PubMed)

Mansour MA, Mahmoud AA, Geddawy M. Nonopioid versus opioid based general anesthesia technique for bariatric surgery: A randomized double-blind study. Saudi J Anaesth. 2013 Oct;7(4):387-91. doi: 10.4103/1658-354X.121045.

Reference Type RESULT
PMID: 24348288 (View on PubMed)

Soffin EM, Wetmore DS, Beckman JD, Sheha ED, Vaishnav AS, Albert TJ, Gang CH, Qureshi SA. Opioid-free anesthesia within an enhanced recovery after surgery pathway for minimally invasive lumbar spine surgery: a retrospective matched cohort study. Neurosurg Focus. 2019 Apr 1;46(4):E8. doi: 10.3171/2019.1.FOCUS18645.

Reference Type RESULT
PMID: 30933925 (View on PubMed)

Bakan M, Umutoglu T, Topuz U, Uysal H, Bayram M, Kadioglu H, Salihoglu Z. [Opioid-free total intravenous anesthesia with propofol, dexmedetomidine and lidocaine infusions for laparoscopic cholecystectomy: a prospective, randomized, double-blinded study]. Rev Bras Anestesiol. 2015 May-Jun;65(3):191-9. doi: 10.1016/j.bjan.2014.05.006. Epub 2014 Nov 1. Portuguese.

Reference Type RESULT
PMID: 25990496 (View on PubMed)

Toleska M, Dimitrovski A. Is Opioid-Free General Anesthesia More Superior for Postoperative Pain Versus Opioid General Anesthesia in Laparoscopic Cholecystectomy? Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019 Oct 1;40(2):81-87. doi: 10.2478/prilozi-2019-0018.

Reference Type RESULT
PMID: 31605587 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

INSSA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pilot Trial: Postoperative Opioid-free Analgesia
NCT04254679 COMPLETED PHASE2/PHASE3